Hormel Reaffirms Guidance, Sheds Turkey Business Amid Growth

Event summary

  • Hormel Foods preliminarily reported Q1 2026 net sales of $3 billion, representing 2% organic growth.
  • The company reaffirmed its full-year adjusted guidance for organic net sales and adjusted diluted EPS.
  • Hormel announced a definitive agreement to sell its whole-bird turkey business to Life-Science Innovations (LSI).
  • The transaction is expected to close by the end of Hormel's second fiscal quarter of 2026.
  • Jeff Ettinger, interim CEO, will present at the CAGNY conference on February 18, 2026.

The big picture

Hormel's decision to divest its whole-bird turkey business aligns with a broader trend among large food companies to streamline portfolios and focus on higher-growth, higher-margin segments. The reaffirmation of full-year guidance, despite the divestiture, suggests underlying business strength, but the company's ability to maintain this momentum will be key to long-term value creation. The sale allows Hormel to reallocate capital and resources to more strategic areas, potentially accelerating its transformation into a more focused branded food company.

What we're watching

Portfolio Dynamics
The minimal impact of the turkey business sale on Hormel’s overall guidance suggests the segment was a relatively small contributor, but the divestiture signals a continued focus on higher-margin, branded products.
Growth Sustainability
Whether Hormel can sustain its five consecutive quarters of organic net sales growth will depend on its ability to innovate and maintain pricing power in a competitive market.
Execution Risk
The success of Hormel's broader strategic initiatives, as outlined at the CAGNY conference, will be critical to achieving its long-term growth algorithm of 2-3% organic net sales and 5-7% operating profit growth.

Related topics

Revenue